|
C5ORF15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.63149527010864E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09340003717762E-09 |
| Normal-vs-Stage2 |
2.675900E-03 |
| Normal-vs-Stage3 |
1.283360E-03 |
| Normal-vs-Stage4 |
5.03670000040479E-07 |
| Stage1-vs-Stage2 |
4.657800E-01 |
| Stage1-vs-Stage3 |
8.135400E-01 |
| Stage1-vs-Stage4 |
4.905800E-01 |
| Stage2-vs-Stage3 |
4.253600E-01 |
| Stage2-vs-Stage4 |
7.599200E-01 |
| Stage3-vs-Stage4 |
4.692600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.56017429478561E-12 |
| Normal-vs-AfricanAmerican |
5.257900E-02 |
| Normal-vs-Asian |
3.829500E-02 |
| Caucasian-vs-AfricanAmerican |
7.358000E-03 |
| Caucasian-vs-Asian |
6.542600E-01 |
| AfricanAmerican-vs-Asian |
6.555200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.62690000255128E-09 |
| Normal-vs-Female |
4.80549999792856E-09 |
| Male-vs-Female |
5.696800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.725400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.33599994903244E-09 |
| Normal-vs-Age(61-80Yrs) |
3.56529999967492E-08 |
| Normal-vs-Age(81-100Yrs) |
9.336200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.816500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.333860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.135600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.953200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.593200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.157800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.030400E-02 |
| Normal-vs-Grade 2 |
3.32539999980952E-08 |
| Normal-vs-Grade 3 |
2.64600008570426E-10 |
| Normal-vs-Grade 4 |
7.295400E-03 |
| Grade 1-vs-Grade 2 |
6.685400E-01 |
| Grade 1-vs-Grade 3 |
8.900200E-01 |
| Grade 1-vs-Grade 4 |
4.234400E-01 |
| Grade 2-vs-Grade 3 |
6.371200E-01 |
| Grade 2-vs-Grade 4 |
3.703800E-02 |
| Grade 3-vs-Grade 4 |
6.273500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.70619074424394E-12 |
| Normal-vs-ccB subtype |
1.119610E-02 |
| ccA subtype-vs-ccB subtype |
3.605200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02649999611515E-08 |
| Normal-vs-N1 |
3.830100E-02 |
| N0-vs-N1 |
8.147400E-01 |
|
|
